Snapshot from Aug 14, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities class action

Insulet Securities Fraud Class Action

Analysis based on 7 articles · First reported Aug 06, 2026 · Last updated Aug 13, 2026

Sentiment
-30
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The lawsuit could negatively affect Insulet's stock price and investor confidence, potentially leading to financial penalties and remediation costs. The market may react to the allegations of manufacturing defects and misleading disclosures, impacting the company's reputation and future sales.

Medical Devices

Schall Brown & Schwartz LLP has filed a securities class action lawsuit against Insulet Corporation, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The complaint claims Insulet made false and misleading statements regarding defective manufacturing controls, which led to increased safety violation risks and a March 2026 Medical Device Correction affecting more Pod products than disclosed. The class period runs from February 21, 2025 to May 26, 2026, with a lead plaintiff deadline of August 31, 2026. Investors who purchased PODD shares during this period may be eligible for compensation.

90 Insulet Corporation disclosed manufacturing issue
stock
Insulet is the defendant in the securities fraud lawsuit, facing allegations of false statements and manufacturing defects. The litigation could result in financial damages, regulatory scrutiny, and reputational harm.
Importance 100.0 Sentiment -40.0
priv
The law firm filed the class action lawsuit on behalf of investors, seeking to recover losses. This action enhances the firm's profile in shareholder litigation.
Importance 80.0 Sentiment 10.0
govactor
The SEC is referenced as the promulgator of Rule 10b-5, but is not a direct party. The lawsuit may draw regulatory attention to Insulet's practices.
Importance 30.0 Sentiment 0.0
per
David Schwartz (disambiguation) is a partner at the law firm and a contact for investors, involved in the case.
Importance 20.0 Sentiment 0.0
per
Brian Schall is a partner at the law firm and a contact for investors, playing a role in the litigation.
Importance 20.0 Sentiment 0.0
per
Andrew Brown is a partner at the law firm, contributing to the litigation efforts.
Importance 20.0 Sentiment 0.0
David Schwartz (disambiguation) founding partner Brian Schall David Schwartz is a founding partner of Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, alo
David Schwartz (disambiguation) founding partner Andrew Brown David Schwartz is a founding partner at Schall, Brown & Schwartz LLP, collaborating with Andrew Brown on various securit
Brian Schall co-founder Andrew Brown Brian Schall is a co-founder and partner with Andrew Brown at Schall, Brown & Schwartz LLP, collaborating on securities
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.